Cardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated with Thrombolysis

BACKGROUND: Trimetazidine is an anti-ischemic agent with anti-oxidant activity. This study sought to evaluate the impact of oral trimetazidine on extent of myocardial damage in diabetic patients who were presented with anterior wall ST-segment elevation myocardial infarction (STEMI). METHODS: One hu...

Descripción completa

Detalles Bibliográficos
Autor principal: Shehata, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358175/
https://www.ncbi.nlm.nih.gov/pubmed/28392876
http://dx.doi.org/10.14740/cr330w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358175/
https://www.ncbi.nlm.nih.gov/pubmed/28392876
http://dx.doi.org/10.14740/cr330w

Ejemplares similares